CAMP4 Therapeutics Corporation
- CAMP
- NASDAQ
- Biotechnology
- RNA-Targeted Therapeutics
- Drug Development
$3.17
Today −8.12%Quote Oct 16, 2026, 08:00 PM UTC
−21.34%over the last month
Max drawdown −25.2%From 1-month high −25.2%3 months −4.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$198.9M
Quote Oct 16
Next earnings
—
Data unavailable
Analyst target
$9.67
+205.0% from here
Floor
$3.16
0.2% below price
Where the price sits
24 analysts
Analyst range, low to high
$6.00$15.00
- Price $3.17
- Resistance $3.19
- Consensus $9.67
The price is just above its floor and right under resistance. Analysts' average target sits about 205% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CAMPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q4 2023 revenue $53.6M
- Product$31.2M58.2%
- Application Subscriptions And Other Services$22.4M41.8%
Industry
Biotechnology
Employees
48